Amneal Pharmaceuticals, Inc. (AMRX)
21.38
-0.32
(-1.50%)
USD |
NASDAQ |
Nov 13, 16:00
21.38
0.00 (0.00%)
After-Hours: 19:59
Amneal Pharmaceuticals Market Cap : 7.446B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.560B |
| November 11, 2026 | 7.563B |
| November 10, 2026 | 7.448B |
| November 09, 2026 | 7.413B |
| November 06, 2026 | 7.016B |
| November 05, 2026 | 6.776B |
| November 04, 2026 | 6.371B |
| November 03, 2026 | 6.454B |
| November 02, 2026 | 6.527B |
| October 30, 2026 | 6.869B |
| October 29, 2026 | 6.818B |
| October 28, 2026 | 6.751B |
| October 27, 2026 | 6.846B |
| October 26, 2026 | 6.712B |
| October 23, 2026 | 6.508B |
| October 22, 2026 | 6.540B |
| October 21, 2026 | 6.450B |
| October 20, 2026 | 6.336B |
| October 19, 2026 | 6.182B |
| October 16, 2026 | 6.125B |
| October 15, 2026 | 6.147B |
| October 14, 2026 | 6.035B |
| October 13, 2026 | 6.249B |
| October 12, 2026 | 6.396B |
| October 09, 2026 | 6.358B |
| Date | Value |
|---|---|
| October 08, 2026 | 6.275B |
| October 07, 2026 | 6.275B |
| October 06, 2026 | 6.481B |
| October 05, 2026 | 6.498B |
| October 02, 2026 | 6.482B |
| October 01, 2026 | 6.409B |
| September 30, 2026 | 6.431B |
| September 29, 2026 | 6.450B |
| September 28, 2026 | 6.546B |
| September 25, 2026 | 6.313B |
| September 24, 2026 | 6.324B |
| September 23, 2026 | 6.173B |
| September 22, 2026 | 6.227B |
| September 21, 2026 | 6.438B |
| September 18, 2026 | 5.975B |
| September 17, 2026 | 5.837B |
| September 16, 2026 | 5.773B |
| September 15, 2026 | 5.317B |
| September 14, 2026 | 5.499B |
| September 11, 2026 | 5.432B |
| September 10, 2026 | 5.387B |
| September 09, 2026 | 5.508B |
| September 08, 2026 | 5.445B |
| September 04, 2026 | 5.569B |
| September 03, 2026 | 5.706B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TG Therapeutics, Inc. | 9.747B |
| Pfizer Inc. | 164.73B |
| Liquidia Corp. | 5.153B |
| Johnson & Johnson | 688.44B |
| Eli Lilly & Co. | 1.360T |
Market Cap Related Metrics
| PE Ratio | 52.48 |
| PS Ratio | 2.209 |
| PEG Ratio | 0.0188 |
| Price to Book Value | 14.02 |
| Price | 21.38 |
| Earnings Yield | 1.91% |
| PEGY Ratio | 0.0188 |
| Operating PE Ratio | 13.43 |
| Normalized PE Ratio | 39.34 |